Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1170 | 1037 | 1322 | 937 | 1475 | 2312 |
Fund Return | 16.98% | 3.65% | 32.16% | -2.13% | 8.08% | 8.74% |
Place in category | 725 | 899 | 1329 | 1782 | 1222 | 390 |
% in Category | 26 | 35 | 48 | 76 | 68 | 44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities I USD Acu | 3.14B | 24.04 | 7.75 | - | ||
Cleome Index USA Equities Z USD Acc | 3.08B | 24.19 | 7.88 | 12.43 | ||
Cleome Index USA Eq C USD Inc | 3.08B | 23.07 | 6.85 | - | ||
Cleome Index USA Eq C USD Acc | 3.08B | 23.07 | 6.84 | 11.23 | ||
RBC Lux GlblEqFocus Class C USD Cap | 1.74B | 18.00 | -1.06 | 9.97 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux ZLgd | 15.93B | 18.28 | 3.62 | 10.80 | ||
Cap Group New Perspective lux C | 15.73B | 17.04 | 2.93 | - | ||
Cap Group New Perspective lux ZL | 15.73B | 16.33 | 2.33 | 10.85 | ||
Cap Group New Perspective lux A7 | 15.73B | 16.51 | 2.48 | - | ||
Cap Group New Perspective lux ZLd | 15.73B | 16.42 | 2.36 | 10.86 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.46 | 430.59 | +1.42% | |
Amazon.com | US0231351067 | 4.97 | 225.96 | +2.40% | |
UnitedHealth | US91324P1021 | 4.49 | 514.11 | +0.69% | |
Home Depot | US4370761029 | 3.69 | 409.76 | +0.11% | |
HCA | US40412C1018 | 3.68 | 312.03 | +0.84% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review